Platforms

Pipeline generator & drug discovery tool

Assets

Developing Phase 3 ready combination drugs

Building an exciting pipeline

 

Rejuvenate Biomed One Pager

Highlights

Positive results Phase 1b trial in sarcopenia

Primary and secondary endpoints have been met in this placebo-controlled study in disuse-induced muscle atrophy. RJx-01 was safe and well tolerated and the innovative formulation confirmed excellent pharmacokinetics.
LEARN MORE

Acknowledgements and investors